Evidence map›Paper›PMID 34878233›Full record

ReviewNursing open2022

Age-related differences in self-report and objective measures of cognitive function in older patients prior to chemotherapy.

Inger Utne, Borghild Løyland, Ellen Karine Grov, Hege Lund Rasmussen, Ann Helen Torstveit, Steven M Paul, Christine Ritchie, Kristina Lindemann, Ingvild Vistad, Claudia Rodríguez-Aranda and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nursing open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Incidence and predictors of immune checkpoint inhibitor treatment-related cognitive impairment in a racial and ethnic diverse population.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Inger UtneDepartment of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.ORCID 0000-0001-8892-079X
Borghild LøylandDepartment of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.ORCID 0000-0002-8044-7990
Ellen Karine GrovDepartment of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Hege Lund RasmussenDepartment of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Ann Helen TorstveitDepartment of Nursing and Health Promotion, Faculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Steven M PaulSchool of Nursing, University of California, San Francisco, California, USA.
Christine RitchieDivision of Palliative Care and Geriatric Medicine, Massachusetts General Hospital Morgan Institute, Boston, Massachusetts, USA.
Kristina LindemannDepartment of Gynecological Oncology, Oslo University Hospital, Oslo, Norway.
Ingvild VistadDepartment of Obstetrics and Gynecology, Hospital of Southern Norway, Kristiansand, Norway.ORCID 0000-0002-5262-6326
Claudia Rodríguez-ArandaDepartment of Psychology, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Christine MiaskowskiSchool of Nursing, University of California, San Francisco, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimEvaluate for differences in demographic and clinical characteristics and subjective and objective measures of cognitive function (CF) between younger older adults (YOA, 60-69 years) and older adults (OA, ≥70 years).

designCross-sectional.

methodsOlder oncology patients (n = 139) completed subjective (Attentional Function Index, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC) CF scale) and objective (Montreal Cognitive Assessment, Trail Making Test (TMT) A & B) measures of CF prior to chemotherapy. Data were analyzed using parametric and nonparametric tests.

resultsNo differences were found between the two groups for any of the subjective or objective CF measures, except that OA patients had higher TMT B scores. Compared with the general population, OAs had significantly higher EORTC CF scores and YOAs had significantly worse scores for all of the objective tests. Clinically meaningful difference between group differences was found for the TMT B test.

Indexed as

CognitionQuality of LifeAgedCross-Sectional StudiesHumansSelf ReportTrail Making Testcancercognitive functionolder adultpatient-reported outcomesperformance-based outcomes

Identifiers

PMID34878233
PMCPMC8859071

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.